Protective efficacy of adenovirus-protein vaccines against SIV.pdfVIP

Reports vaccine candidates. We Protective efficacy of adenovirus-protein previously showed that priming with adenovirus vectors and vaccines against SIV challenges in rhesus boosting with poxvirus vectors expressing Env, Gag, and Pol monkeys resulted in a reduced per- exposure acquisition risk after